Medical and public concern about a controversial UK trial of puberty blockers is on the rise, as are efforts to derail it. The clinical Pathways trial is due to begin recruiting children and ...

On Monday, the New York Times published an article billed as an in-depth look at puberty blockers as a treatment for gender dysphoria in youth. It wasn’t a guide to the science of the medication, or ...

“It is unconscionable to coerce young people into participating and, for half of the cohort, delay the care they’ve been ...

WELLINGTON (Reuters) -New Zealand said on Wednesday it was banning new prescriptions of puberty blocking drugs for young transgender people, in a move that critics warned could worsen the mental ...

Legal advocacy group ADF International has called for an end to “reckless experimentation on children” by the NHS, which has ...

Details of a new UK clinical trial to assess the risks and benefits of puberty-blocking drugs in children who question their gender have been announced. It follows the banning of the drugs for gender ...

Senior doctors, scientists, psychologists and medical ethics experts are urging ministers to halt a controversial NHS puberty ...

On 17 December Radio New Zealand reported the decision of the High Court to delay the ban on puberty blockers (a non-medical intervention) to treat gender dysphoria in young people pending a judicial ...

Parliament will consider this for a debate,” the Parliament UK webpage will inform you, magnanimously, when you add your name to the petition – something I hope you’ll do as soon as you finish reading ...

America First Legal (AFL) sued the Food and Drug Administration on Friday to obtain Biden-era records related to the government’s internal guidance for the recommended use of puberty blockers for kids ...